THE EFFECT OF SMALL DOSE OF ALDOSE REDUCTASE INHIBITOR (SORBINIL) ON DIABETIC NEUROPATHY

被引:0
|
作者
LEHTINEN, J
HYVONEN, K
KILPELAINEN, H
UUSITUPA, M
PUHAKAINEN, E
PARTANEN, J
RIEKKINEN, P
机构
[1] UNIV KUOPIO,CENT HOSP,DEPT NEUROL,SF-70101 KUOPIO 10,FINLAND
[2] UNIV KUOPIO,CENT HOSP,DEPT MED,SF-70101 KUOPIO 10,FINLAND
[3] UNIV KUOPIO,CENT HOSP,DEPT CLIN CHEM,SF-70101 KUOPIO 10,FINLAND
来源
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:198 / 199
页数:2
相关论文
共 50 条
  • [31] CLINICAL-TRIAL OF AN ALDOSE REDUCTASE INHIBITOR IN DIABETIC NEUROPATHY
    HANDELSMAN, DJ
    TURTLE, JR
    DIABETES, 1981, 30 (06) : 459 - 464
  • [32] WITHDRAWAL OF THE ALDOSE REDUCTASE INHIBITOR TOLRESTAT IN PATIENTS WITH DIABETIC NEUROPATHY - EFFECT ON NERVE FUNCTION
    SANTIAGO, JV
    SONKSEN, PH
    BOULTON, AJM
    MACLEOD, A
    BEG, M
    BOCHENEK, W
    GRAEPEL, GJ
    GONEN, B
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 1993, 7 (03) : 170 - 178
  • [33] THE EFFECT OF ALDOSE REDUCTASE INHIBITION ON HUMAN DIABETIC NEUROPATHY
    SIMA, AAF
    NATHANIEL, V
    BRIL, V
    GREENE, DA
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1987, 46 (03): : 380 - 380
  • [34] Effect of a combination treatment with a low dose of an aldose reductase inhibitor and a protein kinase C-β specific inhibitor on diabetic neuropathy in rats
    Nakamura, J
    Hamada, Y
    Chaya, S
    Komori, T
    Kato, K
    Kasuya, Y
    Ienaga, K
    Hotta, N
    DIABETES, 1999, 48 : A53 - A54
  • [35] FURTHER CLINICAL-STUDIES WITH AN ALDOSE REDUCTASE INHIBITOR IN DIABETIC NEUROPATHY
    VANGERVEN, JMA
    DIABETIC MEDICINE, 1993, 10 (05) : S35 - S38
  • [36] ALDOSE REDUCTASE INHIBITION FOR DIABETIC NEUROPATHY
    ABRAHAM, RR
    ABRAHAM, RM
    WYNN, V
    LANCET, 1983, 2 (8356): : 969 - 969
  • [37] EXPERIMENTAL AND CLINICAL-TRIAL OF ALDOSE REDUCTASE INHIBITOR IN DIABETIC NEUROPATHY
    HOTTA, N
    KAKUTA, H
    KIMURA, M
    FUKASAWA, H
    KOH, N
    TERASHIMA, H
    IIDA, M
    SAKAMOTO, N
    DIABETES, 1983, 32 : A98 - A98
  • [38] ALDOSE REDUCTASE INHIBITOR (TOLRESTAT) THERAPY IN PATIENTS WITH DIABETIC PERIPHERAL NEUROPATHY
    HARATI, Y
    NIAKAN, E
    COMSTOCK, JP
    LOGAN, C
    ANNALS OF NEUROLOGY, 1987, 22 (01) : 129 - 129
  • [39] POLYOL PATHWAY AND DIABETIC NEUROPATHY - SELECTIVE PREVENTIVE EFFECTS OF AN ALDOSE REDUCTASE INHIBITOR IN EXPERIMENTAL DIABETIC NEUROPATHY
    KAMIJO, M
    YAGIHASHI, S
    JAPANESE JOURNAL OF MEDICINE, 1991, 30 (06) : 629 - 630
  • [40] Effect of zenarestat, an aldose reductase inhibitor, on endoneurial blood flow in experimental diabetic neuropathy of rat
    Kihara, M
    Mitsui, Y
    Shioyama, M
    Hasegawa, T
    Takahashi, M
    Takakura, S
    Minoura, K
    Kawamura, I
    NEUROSCIENCE LETTERS, 2001, 310 (2-3) : 81 - 84